CAS: 1009119-64-5 - BMS-790052

Formel: C₄₀H₅₀N₈O₆

InChl: InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1

InChI Key: InChIKey=FKRSSPOQAMALKA-CUPIEXAXSA-N

SMILES: O=C(OC)NC(C(=O)N1CCCC1C2=NC=C(N2)C=3C=CC(=CC3)C=4C=CC(=CC4)C5=CN=C(N5)C6N(C(=O)C(NC(=O)OC)C(C)C)CCC6)C(C)C

Synonyme:

• Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester
• Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester
• Daclatasvir
• Daclavirocyrl
• Daklanork
• Ebp 883
• Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-5-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate
• dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate

Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester

CAS: 1009119-64-5

• Formel: C₄₀H₅₀N₈O₆
• Reinheit: ≥98%
• Farbe und Form: Solid
• Molekulargewicht: 738.8750

Daclatasvir-d6

CAS: 1009119-64-5

• Formel: C₄₀H₄₄D₆N₈O₆
• Farbe und Form: Off-White To Pale Yellow Solid
• Molekulargewicht: 744.93

Daclatasvir-d16

CAS: 1009119-64-5

• Formel: C₄₀H₃₄D₁₆N₈O₆
• Farbe und Form: Yellow Solid
• Molekulargewicht: 754.99

Daclatasvir

CAS: 1009119-64-5

Daclatasvir (EBP 883) (BMS-790052) is a highly selective inhibitor of HCV NS5A with EC50 of …

• Formel: C₄₀H₅₀N₈O₆
• Reinheit: 99.81%
• Farbe und Form: Solid
• Molekulargewicht: 738.88

Daclatasvir

CAS: 1009119-64-5

Applications Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug …

• Formel: C₄₀H₅₀N₈O₆
• Farbe und Form: Neat
• Molekulargewicht: 738.88

Daclatasvir-d6

CAS: 1009119-64-5

• Formel: C₄₀D₆H₄₄N₈O₆
• Farbe und Form: Neat
• Molekulargewicht: 744.912

Daclatasvir

CAS: 1009119-64-5

Daclatasvir is a drug that is used to treat hepatitis C virus (HCV) and is …

• Formel: C₄₀H₅₀N₈O₆
• Reinheit: Min. 95%
• Molekulargewicht: 738.88 g/mol